FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 120 filers reported holding FUSION PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 2.85 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $40,892,357 | – | 1,918,028 | – | 3.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,502,425 | $39,994,000 | 10.54% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $44,120,000 | 8.88% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $30,673,000 | 0.55% |
| Orbimed Advisors | 3,224,770 | $38,762,000 | 0.49% |
| Perceptive Advisors | 2,235,983 | $26,877,000 | 0.39% |
| CLOUGH CAPITAL PARTNERS L P | 402,800 | $4,842,000 | 0.35% |
| Rock Springs Capital Management LP | 947,541 | $11,389,000 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 972,046 | $11,684,000 | 0.28% |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 | $37,466,000 | 0.07% |
| Woodline Partners LP | 76,093 | $915,000 | 0.03% |